News | June 20, 2011

Breast Tomosynthesis System Wins Top Award in Medical Design Excellence Competition

June 20, 2011 – The Selenia Dimensions 2-D/3-D mammography system won a gold Medical Design Excellence Award (MDEA) at the Medical Design and Manufacturing East 2011 Conference and Exposition. Selenia is manufactured by Hologic.

The Medical Design Excellence Award recognizes Hologic for innovation in design and engineering for Selenia Dimensions, the first commercially available tomosynthesis system for breast cancer screening and diagnosis. Unlike prior-generation mammography systems, which generate two-dimensional (2-D) images, a breast tomosynthesis system produces three-dimensional (3-D) images, which are intended to reveal the inner architecture of the breast, free from the distortion typically caused by tissue shadowing or density.

The Hologic system gives radiologists the option of offering their patients a conventional 2-D digital mammogram and a 3-D tomosynthesis exam – all in one compression, in just seconds.

In clinical studies Hologic submitted to the U.S. Food and Drug Administration (FDA), radiologists reading 2-D mammography plus 3-D breast tomosynthesis images compared to 2-D images alone demonstrated superior clinical performance in specificity, the confidence to rule out breast cancer without recalling the patient for further study, and also demonstrated improved sensitivity, the proportion of mammograms which include breast cancers that were correctly diagnosed.

In accepting the award for Hologic, Ian Shaw, director of breast health advanced product development, noted, "The Medical Design Excellence Award is welcome recognition for the achievements of the many people behind the scenes who are responsible for developing the Selenia Dimensions mammography system." Farm Design Inc., a New England medical product development company, assisted Hologic with the industrial design, human factors, engineering and user interface of the product.

Hologic's 2-D/3-D breast tomosynthesis systems are available for sale worldwide. Selenia Dimensions 3D tomosynthesis was approved for sale in the United States by the FDA on Feb. 11, 2011.

This is the fourth time a Hologic product has won a top award in the MDEA program. The Company's Sentinelle Vanguard breast imaging and interventional coil won gold in 2010. The Sentinelle breast imaging coil transforms a Magnetic Resonance Imaging (MRI) scanner into a powerful breast imaging and interventional tool. Hologic's ThinPrep imaging system won gold in 2004. The ThinPrep imaging system is a fully integrated, interactive computer system that assists cytotechnologists and cytopathologists in the primary screening and diagnosis of cervical cancer using ThinPrep Pap test slides. The MammoSite radiation therapy system won gold in 2003. The MammoSite catheter and balloon assembly delivers radiation from within the tumor-resected cavity after breast conservation therapy. MammoSite targeted radiation therapy works from the inside, meaning that a higher daily dose can be used for a shorter period of time – five days versus five to seven weeks.

For more information: www.hologic.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Videos | Breast Imaging | May 08, 2018
ITN Associate Editor Jeff Zagoudis speaks with Karen Hou, M.D., breast radiologist at Northwestern Medicine Central D
Computer Error Leads to 450,000 Missed U.K. Breast Screening Invites
News | Mammography | May 02, 2018
Since 2009, approximately 450,000 women around age 70 in the United Kingdom did not receive final breast screening...
Pilot Study Initiated for Blood-Based Breast Test
News | Oncology Diagnostics | May 01, 2018
Overlake Medical Center in Bellevue, Wash., announced it has enrolled 85 patients in a pilot study of a blood test to...
Overlay Init